Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Melanoma D008545 69 associated lipids
Memory Disorders D008569 33 associated lipids
Meningioma D008579 11 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Migraine Disorders D008881 11 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Multiple Trauma D009104 2 associated lipids
Nasal Polyps D009298 26 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nerve Degeneration D009410 53 associated lipids
Nervous System Diseases D009422 37 associated lipids
Neuralgia D009437 28 associated lipids
Neuroblastoma D009447 66 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Neutropenia D009503 15 associated lipids
Osteonecrosis D010020 5 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Handa RK et al. Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney. 1991 Am. J. Physiol. pmid:1907104
Sirois MG and Edelman ER VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. 1997 Am. J. Physiol. pmid:9227554
Tomeo AC and Durán WN Resistance and exchange microvessels are modulated by different PAF receptors. 1991 Am. J. Physiol. pmid:1659229
Hines KL and Fisher RA Regulation of hepatic glycogenolysis and vasoconstriction during antigen-induced anaphylaxis. 1992 Am. J. Physiol. pmid:1375439
Whittle BJ et al. Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa. 1986 Am. J. Physiol. pmid:3789144
Zimmerman BJ et al. Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. 1994 Am. J. Physiol. pmid:8160832
Toyofuku T et al. Pulmonary vascular response to platelet-activating factor in conscious sheep. 1988 Am. J. Physiol. pmid:3414811
Gaboury J et al. Nitric oxide prevents leukocyte adherence: role of superoxide. 1993 Am. J. Physiol. pmid:8214120
Asako H et al. Phalloidin prevents leukocyte emigration induced by proinflammatory stimuli in rat mesentery. 1992 Am. J. Physiol. pmid:1362329
DeFily DV et al. PAF attenuates endothelium-dependent coronary arteriolar vasodilation. 1996 Am. J. Physiol. pmid:8764261
McGowan HM et al. Increased aortic PGI2 and plasma lyso-PAF in the unclipped one-kidney hypertensive rat. 1986 Am. J. Physiol. pmid:3538908
Harris NR et al. Influence of arteriovenular pairing on PAF-induced capillary filtration. 1999 Am. J. Physiol. pmid:9887023
Munoz NM et al. Effects of PAF on isolated rat airways perfused with blood-free solution. 1991 Am. J. Physiol. pmid:2018147
Yamazaki M et al. Modulation of leukotriene B4 and platelet-activating factor binding to neutrophils. 1991 Am. J. Physiol. pmid:1653524
Hasunuma K et al. Endothelin 1 causes pulmonary vasodilation in rats. 1990 Am. J. Physiol. pmid:2115743
Bosch RJ et al. Effects of parathyroid hormone-related protein on human mesangial cells in culture. 1999 Am. J. Physiol. pmid:10600786
Schlondorff D et al. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells. 1986 Am. J. Physiol. pmid:3087218
Schlondorff D and Neuwirth R Platelet-activating factor and the kidney. 1986 Am. J. Physiol. pmid:3089026
Wallace JL et al. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock. 1990 Am. J. Physiol. pmid:2372058
Buerke M et al. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. 1994 Am. J. Physiol. pmid:8304493
Findlay SR et al. Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine. 1981 Am. J. Physiol. pmid:7282914
Montrucchio G et al. Release of platelet-activating factor from ischemic-reperfused rabbit heart. 1989 Am. J. Physiol. pmid:2539755
Zheng ZG et al. Platelet-activating factor stimulates resorption by rabbit osteoclasts in vitro. 1993 Am. J. Physiol. pmid:8430791
Conyers G et al. A factor in serum lowers resistance and opens tight junctions of MDCK cells. 1990 Am. J. Physiol. pmid:2221039
Kvietys PR et al. Ethanol enhances leukocyte-endothelial cell interactions in mesenteric venules. 1990 Am. J. Physiol. pmid:2221068
Harris NR et al. Capillary filtration during acute inflammation: role of adherent neutrophils. 1993 Am. J. Physiol. pmid:7902014
Kalra VK et al. Hypoxia induces PECAM-1 phosphorylation and transendothelial migration of monocytes. 1996 Am. J. Physiol. pmid:8945922
Kelly KJ et al. An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury. 1996 Am. J. Physiol. pmid:8946001
Ardaillou N et al. Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells. 1985 Am. J. Physiol. pmid:3918460
Huang YC et al. Superoxide dismutase potentiates platelet-activating factor-induced injury in perfused lung. 1994 Am. J. Physiol. pmid:7513130
Zhou W et al. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats. 1992 Am. J. Physiol. pmid:1443133
Galens S et al. Assessment of agonist- and cell-mediated responses in airway microsections by computerized videomicrometry. 1995 Am. J. Physiol. pmid:7900832
Bussolino F et al. Platelet activating factor induces dopamine release in PC-12 cell line. 1988 Am. J. Physiol. pmid:3177629
Bienvenu K et al. Modulation of leukocyte migration in mesenteric interstitium. 1994 Am. J. Physiol. pmid:7943404
Church DJ et al. Calcium influx in platelet activating factor-induced atrial natriuretic peptide release in rat cardiomyocytes. 1994 Am. J. Physiol. pmid:8166260
Gulbins E et al. Effects of rC5a on the circulation of normal and split hydronephrotic rat kidneys. 1993 Am. J. Physiol. pmid:8342619
Hanglow AC et al. Effects of platelet-activating factor on ion transport in isolated rat jejunum. 1989 Am. J. Physiol. pmid:2597284
Sánchez-Crespo M et al. Presence in normal human urine of a hypotensive and platelet-activating phospholipid. 1983 Am. J. Physiol. pmid:6859262
Rabe KF et al. Contraction of human bronchial smooth muscle caused by activated human eosinophils. 1994 Am. J. Physiol. pmid:7943259
Koyama S et al. Type II pneumocytes release chemoattractant activity for monocytes constitutively. 1997 Am. J. Physiol. pmid:9176245
Kobayashi I et al. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C. 1994 Am. J. Physiol. pmid:8160825
Stahl GL et al. Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists. 1997 Am. J. Physiol. pmid:9227410
Arnould T et al. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. 1993 Am. J. Physiol. pmid:8098907
Kubes P et al. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. 1990 Am. J. Physiol. pmid:2240225
Sobhani I et al. Platelet-activating factor stimulates gastric acid secretion in isolated rabbit gastric glands. 1995 Am. J. Physiol. pmid:7611410
Marchetti J et al. The parietal sheet of Bowman's capsule of rat renal glomerulus: a target of endothelin and PAF. 1995 Am. J. Physiol. pmid:7611446
Shibamoto T et al. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs. 1993 Am. J. Physiol. pmid:8498559
Miller MJ et al. SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. 1988 Am. J. Physiol. pmid:2847541
Wallace JL Lipid mediators of inflammation in gastric ulcer. 1990 Am. J. Physiol. pmid:2405704
Faden AI and Tzendzalian PA Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma. 1992 Am. J. Physiol. pmid:1415805